Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

FFA and FAPD might be related or stages of the same disease.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

A woman had skin and hair issues after a botulinum toxin injection.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Macrophages help activate hair follicle stem cells, affecting hair growth and skin repair.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Alternative treatments show promise for hair growth beyond traditional methods.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.